RECORD #201393
428576922 | LVSMH | 25539207 | | 9744705 | 0/3/2006 12:00:00 AM | transaminitis , CBD dilitation , pancreatic duct dilitation s/p stenting , s/p sphinterectomy | | DIS | Admission Date: 6/6/2006 Report Status:
Discharge Date: 8/14/2006
****** FINAL DISCHARGE ORDERS ******
FLEITMAN , BENNETT V 276-23-13-6
X36 Room: Te Tarage A Cam Seymasa , Indiana 06498
Service: MED
DISCHARGE PATIENT ON: 10/18/06 AT 02:00 PM
CONTINGENT UPON Not Applicable
WILL D/C ORDER BE USED AS THE D/C SUMMARY: YES
Attending: CAFARO , ADALBERTO E. , M.D.
CODE STATUS:
Full code
DISPOSITION: Rehabilitation
DISCHARGE MEDICATIONS:
ENTERIC COATED ASPIRIN ( BABY ) ( ASPIRIN ENTERI... )
162 MG PO DAILY
LIPITOR ( ATORVASTATIN ) 10 MG PO DAILY
Alert overridden: Override added on 10/18/06 by :
POTENTIALLY SERIOUS INTERACTION: NIACIN , VIT. B-3 &amp;
ATORVASTATIN CALCIUM Reason for override: md aware
CALCIUM CARBONATE ( 500 MG ELEMENTAL CA++ ) 500 MG PO TID
NEXIUM ( ESOMEPRAZOLE ) 20 MG PO DAILY
HYDROCHLOROTHIAZIDE 25 MG PO DAILY
INSULIN 70/30 HUMAN 20 UNITS SC QAM
AVAPRO ( IRBESARTAN ) 150 MG PO DAILY
Alert overridden: Override added on 9/14/06 by :
POTENTIALLY SERIOUS INTERACTION: POTASSIUM CHLORIDE &amp;
IRBESARTAN
POTENTIALLY SERIOUS INTERACTION: POTASSIUM CHLORIDE &amp;
IRBESARTAN Reason for override: md Previous Alert overridden
Override added on 9/14/06 by :
POTENTIALLY SERIOUS INTERACTION: POTASSIUM CHLORIDE &amp;
IRBESARTAN
POTENTIALLY SERIOUS INTERACTION: POTASSIUM CHLORIDE &amp;
IRBESARTAN Reason for override: aware
Previous Alert overridden
Override added on 5/27/06 by ENCE , TY R. , M.D.
POTENTIALLY SERIOUS INTERACTION: POTASSIUM CHLORIDE &amp;
IRBESARTAN
POTENTIALLY SERIOUS INTERACTION: POTASSIUM CHLORIDE &amp;
IRBESARTAN Reason for override: aware
Previous override reason:
Override added on 5/27/06 by ELWONGER , JOHNNY T. , M.D.
on order for POTASSIUM CHLORIDE IMMED. REL. PO ( ref #
051054779 )
POTENTIALLY SERIOUS INTERACTION: IRBESARTAN &amp; POTASSIUM
CHLORIDE Reason for override: md aware
Previous override information:
Override added on 5/27/06 by RUBIANO , NUMBERS D. , M.D.
on order for POTASSIUM CHLORIDE IV ( ref # 105816142 )
POTENTIALLY SERIOUS INTERACTION: IRBESARTAN &amp; POTASSIUM
CHLORIDE Reason for override: md aware
LEVAQUIN ( LEVOFLOXACIN ) 500 MG PO Q48H
Food/Drug Interaction Instruction
Administer iron products a minimum of 2 hours before or
after a levofloxacin or ciprofloxacin dose dose
If on tube feeds , please cycle ( hold 1 hr before to 2 hr
after ) Take 2 hours before or 2 hours after dairy products.
LOPRESSOR ( METOPROLOL TARTRATE ) 50 MG PO TID
Starting Today ( 4/13 ) HOLD IF: HR&lt;55 OR SBP&lt;110
Food/Drug Interaction Instruction
Take consistently with meals or on empty stomach.
PILOCARPINE 0.5% 2 DROP OS QID Starting Today ( 4/13 )
MULTIVITAMIN THERAPEUTIC ( THERAPEUTIC MULTIVI... )
1 TAB PO DAILY
VITAMIN E ( TOCOPHEROL-DL-ALPHA ) 400 UNITS PO DAILY
ALPHAGAN ( BRIMONIDINE TARTRATE ) 1 DROP OU BID
XALATAN ( LATANOPROST ) 1 DROP OU QPM
DIET: House / Low chol/low sat. fat
ACTIVITY: Walking as tolerated
FOLLOW UP APPOINTMENT( S ):
PCP as scheduled on 9/4 1:30 ,
Stent removal Dr Menietto 10/1 1:30 endoscopy ,
GI Dr Scroggin 2/7 9am ,
ALLERGY: NKA
ADMIT DIAGNOSIS:
abdominal pain
PRINCIPAL DISCHARGE DIAGNOSIS ;Responsible After Study for Causing Admission )
transaminitis , CBD dilitation , pancreatic duct dilitation s/p stenting , s/p sphinterectomy
OTHER DIAGNOSIS;Conditions , Infections , Complications , affecting Treatment/Stay
DM , HTN , Esophageal Ca , glaucoma , PPM
OPERATIONS AND PROCEDURES:
OTHER TREATMENTS/PROCEDURES ( NOT IN O.R. )
s/p ercp stenting and sphinterotomy on 7/0/06
BRIEF RESUME OF HOSPITAL COURSE:
CC: Abd Pain / GNR bacteremia
***
HPI: 88F w DM , HTN , s/p PPM , h/o esoph CA s/p resxn p/w acute onset
diffuse abd pain , somewhat stronger in LLQ , sharp , a/w nausea. Pain
worse with eating. Had loose BMs x 3-4 days , no fevers , some chills.
No CP , no palps , chronic stable DOE. In ED , Abd
CT , U/S , HIDA scan all unremarkble , but 2/4 BCx with GNRs , and was
given Levo/Flagyl.
***
PMH: DM , HTN , TIA/CVA , s/p esoph CA s/p resection , s/p
PPM
***
ALL: NKDA
***
HOME MEDS: Lipitor 10 , Vit E 400 , Pilocarpine , Timolol , Insulin 70/30
20 QAM , HCTZ 25 , PPI , Lopressor 50 bid , Avapro ,
ASA
***
PEx: T96.9 P56 140/46 Sats ok on RA. NAD. Lungs clear , RRR S1/S2.
Abd S/ND. Very mild tenderness , somewhat localized over LLQ.
Hyperactive BS. Ext WWP. NONTOXIC
looking.
***
STUDIES: Abd CT: GB wall thickening , dilatation of
pancreatic duct. HIDA: neg for CBD
dist RUQ U/S: GB
sludge
***
NOTABLE LABS: AST 1425 , ALT 1259 , AlkPhos 198 , TB 1.9 , Amy 90.
Chem 7 / CBC unremarkable. No anion gap. BCx with 2/4
GNRs.
***
A/P: 88F w abd pain of unclear etiology on admission with transaminitis ,
abd pain and suspected bile duct stones and sludge. Underwent ERCP which
demonstrated dilated main pancreatitic duct s/p stenting , dilated CBD
with sludge s/p sphinterectomy. Transaminitis and abd pain have continued
to improve.
***
ID: Given GNR bacteremia , emperically covered with Levo / Ceftaz.
Cx grew pansensitive Kleb , and coverage was narrowed to Levo
to complete a 14 day course. Surveillance cx negative.
GI: Marked transaminitis. No
recent new meds. Hepatitis serologies negative , U/S w Doppler to
r/o Budd-Chiari esp given acute onset negative , Lactate + guaiac for
? mesenteric ischemia( but no gap )negative. No indication for surgery.
GI consulted recommended ERC , results as above. LFTs trending
down s/p sphinterotomy and ERCP. Will f/u with GI in 2 weeks for repeat
ERCP at OEDMC .
CV: Cont Lipitor , HCTZ , Lopressor , Avapro , ASA. No
signs of ischemia , failure. Uptitrated avapro given
persistent HTN , appears to be near maximally BB in terms of heart
rate
OPHTH: Cont eye drops
ENDO: h/o DM , cont insulin + scale.
FEN: Npo pending ercp , adv to clears s/p procedure well tolerated , K/Mg
scales.
Ppx: Nexium / Lovenox
Full Code
ADDITIONAL COMMENTS:
DISCHARGE CONDITION: Stable
TO DO/PLAN:
*f/u with PCP and Gi as scheduled
*return to ED with worsening symptoms of abd pain or if unable to tolera
No dictated summary
ENTERED BY: SALEH , ZACK D. , M.D. ( PN858 ) 10/18/06 @ 02
****** END OF DISCHARGE ORDERS ******
[report_end]
